KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Herbalife (HLF) Cash & Equivalents (2016 - 2025)

Herbalife's Cash & Equivalents history spans 17 years, with the latest figure at $305.5 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 26.9% year-over-year to $305.5 million; the TTM value through Sep 2025 reached $305.5 million, down 26.9%, while the annual FY2023 figure was $595.5 million, 15.34% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $305.5 million at Herbalife, down from $417.9 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $846.3 million in Q2 2021 and bottomed at $305.5 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $544.0 million (2022), against an average of $539.7 million.
  • The largest annual shift saw Cash & Equivalents plummeted 51.59% in 2021 before it grew 15.34% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $610.4 million in 2021, then fell by 15.42% to $516.3 million in 2022, then grew by 15.34% to $595.5 million in 2023, then decreased by 29.82% to $417.9 million in 2024, then decreased by 26.9% to $305.5 million in 2025.
  • Per Business Quant, the three most recent readings for HLF's Cash & Equivalents are $305.5 million (Q3 2025), $417.9 million (Q3 2024), and $389.3 million (Q2 2024).